Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour

NCT00346840 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Labor Induction
Cervical Ripening

Interventions

DRUG: Misoprostol vaginal insert 25 mcg
DRUG: Misoprostol vaginal insert 50 mcg
DRUG: Misoprostol vaginal insert 100 mcg
DRUG: Misoprostol vaginal insert 200 mcg

Sponsor

Ferring Pharmaceuticals